NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Hemagglutinin inhibition (HAI) Assay   Add to my SOP compendium

BRD ID: 1,122

Source: HIMC Tier: SOP Number of times downloaded: 957

Description

This document describes the protocols used by the Human Immune Monitoring Center (HIMC) at Stanford School of Medicine for processing serum and determining hemagglutination using an HAI assay. It is a product of HIMC and is available at https://iti.stanford.edu/himc/protocols.html.

Documents for Download

HAI_Assay072612.pdf [Size: 386 KB]
Biospecimens
  • Fluid - Serum
Diagnoses
  • General
Topics
  • Biospecimen Processing
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • 2025’s Most Popular SOPs: See What Users Downloaded Most
  • Improving RNAseq Analysis of Small Biospecimens: New Recommendations Available
  • 2026 NCI Best Practices for Biospecimen Resources is Now Available!
    • More...